Prakt. lékáren. 2017; 13(1): 7-11 | DOI: 10.36290/lek.2017.001

Combination therapy for hypertension in the year 2017 – the basic knowledge for pharmacists

Stanislav Gregor
Ústavní lékárna, Institut klinické a experimentální medicíny, Praha

In recent years, many guidelines for therapy of arterial hypertension were published. Even so, most patients don´t achieve their

blood pressure target. The reasons could be low compliance or unhealthy lifestyle, but also inadequate use of combination drug

therapy or irrational combinations of antihypertensive agents.

Keywords: hypertension, antihypertensive drugs, combination therapy, fixed combinations

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor S. Combination therapy for hypertension in the year 2017 – the basic knowledge for pharmacists. Praktické lékárenství. 2017;13(1):7-11. doi: 10.36290/lek.2017.001.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lalic J, Radovanovic RV, Mitic B, et al. Medication adherence in outpatients with arterial hypertension. Sci J Fac Med Nis. 2013; 30: 209-218. Go to original source...
    2. Widimský J Jr. Kombinační léčba hypertenze. In: Widimský J, Widimský J Jr. Farmakoterapie hypertenze. Maxdorf Praha 2016: 132-137.
    3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013; 31: 1281-357. Go to original source... Go to PubMed...
    4. Filipovský J, et al. Summary of 2013 ESH/ESC Guidelines for the management of arterial hypertension. Prepared by the Czech Society of Hypertension/Czech Society of Cardiology, Cor et Vasa. 2014; 56: 494-518. Go to original source...
    5. Gradman AH, Parisé H, Lefebvre P, et al. Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched kohort study. Hypertension. 2011; 58(4): 566-572.
    6. Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Medicine 2009; 122(3): 290-300. Go to original source... Go to PubMed...
    7. Taddei S. Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence? Am J Cardiovasc Drugs. 2015; 15(3): 185-194. Go to original source... Go to PubMed...
    8. Špinar J, Vítovec J, Špinarová L, et al. Kombinační léčba hypertenze 2015. Vnitř Lék 2015; 61(5): 458-465.
    9. van Vark LC, Bertrand M, Akkerhuis KM, et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trial sof reninangio-tensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J. 2012; 33: 2088-2097. Go to original source... Go to PubMed...
    10. Saverese G, Costanzo P, Cleland JG, et al. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patient without heart failure. J Am Coll Cardiol. 2013; 61: 131-142. Go to original source... Go to PubMed...
    11. Cheng J, Zhang W, Zhang X, et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA Internal Medicine 2014; 174(5): 773-785. Go to original source... Go to PubMed...
    12. Matsuzaki M, Ogihara T, Umemoto S. Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial. J Hypertens. 2011; 29(8): 1649-1659. Go to original source... Go to PubMed...
    13. Filipovský J, Widimský J Jr., Ceral J, et al. Diagnostické a léčebné postupy u arteriální hypertenze-verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék. 2012; 58: 785-801. Go to PubMed...
    14. Fried LF, Emanuele N, Zhang JH, et al; the VA NEPHRON-D Investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med. 2013; 369: 1892-903. Go to original source... Go to PubMed...
    15. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311(5): 507-520. Go to original source... Go to PubMed...
    16. Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007; 120(8): 713-719. Go to original source... Go to PubMed...
    17. Hess G, Hill J, Lau H, et al. Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose to Free-Combination Antihypertensive Therapy. P T 2008; 33(11): 652-666.
    18. Špinar J, Vítovec J, Špinarová L. Lipertance(R) - dva problémy, jedno řešení. Kardiol Rev Int Med 2016; 18(4): 287-292.
    19. Bertrand M, Mourad JJ. Combining perindopril with calcium channel blocker and a lipid-lowering agent significantly decreases mortality: a subgroup analysis of EUROPA. Circulation 2013;128:A18906.
    20. Automatizovaný informační systém léčivých přípravků. MV AISLP 2016.4. Souhrny údajů o přípravcích (SPC).
    21. http://www.p-i-n.cz/ep/index.php, 23. 1. 2017.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.